Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Ardent Health Partners, LLC (ARDT) has a Wall Street consensus price target of $14.57, based on estimates from 12 covering analysts. With the stock currently trading at $9.39, this represents a potential upside of +55.2%. The company has a market capitalization of $1.34B.
Analyst price targets range from a low of $12.00 to a high of $19.00, representing a 48% spread in expectations. The median target of $14.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ARDT trades at a trailing P/E of 5.9x and forward P/E of 7.4x. The forward PEG ratio of 0.10 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -12.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $13.78, with bear and bull scenarios of $1.05 and $3.53 respectively. Model confidence stands at 58/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ARDT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for ARDT is $14.57, representing 55.2% upside from the current price of $9.39. With 12 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ARDT has a consensus rating of "Buy" based on 12 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $14.57 implies 55.2% upside from current levels.
With a forward P/E of 7.3798x, ARDT trades at a relatively low valuation. The consensus target of $14.57 implies 55.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $19 for ARDT, while the most conservative target is $12. The consensus of $14.57 represents the median expectation. Our quantitative valuation model projects a bull case target of $4 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ARDT is moderately covered, with 12 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 3 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARDT stock forecast based on 12 Wall Street analysts shows a consensus price target of $14.57, with estimates ranging from $12 (bear case) to $19 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $14, with bear/bull scenarios of $1/$4.
Our quantitative valuation model calculates ARDT's fair value at $14 (base case), with a bear case of $1 and bull case of $4. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 58/100.
ARDT trades at a forward P/E ratio of 7.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 5.9x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ARDT, with a "Buy" consensus rating and $14.57 price target (55.2% upside). 8 of 12 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARDT analyst price targets range from $12 to $19, a 48% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $14.57 consensus represents the middle ground. Our model's $1-$4 range provides an independent fundamental perspective.